CurrentCardio Weekly: 9–15 November 2026
Featured
Lancet
Cardiovascular outcomes with survodutide in adults with obesity at increased cardiovascular risk (SYNCHRONIZE-CVOT): a double-blind, randomised, placebo-controlled, phase 3 trial
Randomized controlled trialCardiometabolic & kidney
Circulation
Off-Pump versus On-Pump Coronary Artery Bypass Grafting in Prefrail and Frail Patients: 30-Day and 1-Year Outcomes From the FRAGILE Randomized Trial
Randomized controlled trialCoronary & ACS
Europace
Modified Posterior Wall Ablation in Persistent Atrial Fibrillation: the BOX-AF Randomized Clinical Trial
Randomized controlled trialArrhythmias & EP
Also selected
Eur Heart J Cardiovasc Pharmacother
Beta-blocker therapy and angina burden after myocardial infarction: A prespecified substudy of the BETAMI-DANBLOCK trial
Secondary analysisCoronary & ACS
Eur Heart J Cardiovasc Pharmacother
J Am Coll Cardiol
N Engl J Med
Prevention of Venous Thromboembolism after Total Hip or Knee Replacement
Randomized controlled trialPulmonary vascular & VTE
JAMA Cardiol
Assessment of Coronary Inflammatory Risk From Noncontrast Cardiac Computed Tomography
Diagnostic or prognostic studyCoronary & ACS
BMJ
JAMA Cardiol
First and Subsequent Major Cardiovascular Events With Oral Semaglutide in High-Risk Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial
Secondary analysisCardiometabolic & kidney